The Role of Interleukin-6 and Interleukin-8 Gene Polymorphisms in Non-Alcoholic Steatohepatitis

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)

(2013) Siddharth Verma et al.   LIVER INTERNATIONAL

Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

(2012) Takahisa Kawaguchi et al.   PLoS One

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

(2010) V. B. Matthews et al.   DIABETOLOGIA

Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C

(2010) Edmondo Falleti et al.   HUMAN IMMUNOLOGY

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

(2009) Vincent Wai-Sun Wong et al.   INTERNATIONAL JOURNAL OF CANCER

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences

(2009) Hayato Nakagawa et al.   INTERNATIONAL JOURNAL OF CANCER